Latest Asx News

Pacgold Limited has entered a farm-in agreement to acquire up to 100% of the St George Gold-Antimony Project in North Queensland, unlocking exposure to a critical mineral with soaring prices and strong geopolitical demand.

RocketDNA has secured a three-year contract to deploy its autonomous drone solution at the Gruyere Gold Mine, marking a significant step in integrating AI-powered surveying technology in mining operations.

360 Capital REIT (ASX – TOT) has reported a return to profitability in FY25, extending its debt facility and completing key leasing deals, while preparing for leasing challenges in FY26.

CuFe Ltd announces a remarkable 400% increase in its Gecko copper-gold resource at Tennant Creek, boosting the total project resource to 24.3 million tonnes. This comprehensive update integrates decades of historical data and expands the deposit’s economic potential with byproduct metals.

Highfield Resources faces a setback as China Minmetals and its subsidiary withdraw from a key strategic investment, triggering the maturity of convertible notes and raising questions about the future financing of the Muga potash project.

Pure Resources reaffirms exceptional metallurgical results at its Garnet Hills Project, achieving garnet grades up to 98% through sustainable processing. The company is now scaling up testing and forging strategic collaborations in the US to unlock downstream rare earth opportunities.

Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.

Star Minerals Limited has voluntarily suspended trading on the ASX pending an important announcement related to assay results and a price query. The suspension is expected to last until 20 August or until the announcement is released.

Power Minerals reports compelling high-grade niobium and rare earth element intersections from early-stage auger drilling at its Santa Anna Project in Brazil, extending the known mineralised footprint and reinforcing confidence in a significant resource.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Adrad Holdings reported an 8.9% rise in FY25 sales revenue to $153.1 million despite a slight dip in EBITDA, while declaring a fully franked dividend and outlining strategic initiatives for FY26.